Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Dasatinib × Clear all

NCT00744497 2016-10-17

READY

Phase 3 Completed

1,930 enrolled 23 charts

Prostatic Neoplasms

NCT00439270 2014-03-28

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer

Phase 1/2 Completed

49 enrolled 25 charts

Prostatic Neoplasms

NCT00385580 2013-04-30

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Phase 2 Completed

94 enrolled 50 charts

Prostatic Neoplasms